ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983

Benno Schmidt, 86, Cancer Act Advocate, Chairman Of MSKCC boards, Cancer Panel

October 29, 1999

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

NCI-Approved Clinical Trials Listed For January

January 28, 2005

Conferees Set NIH Funding At $30 Billion.

November 2, 2007